Latest Regulatory News

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.

The National Court of Papua New Guinea has dismissed litigation brought by offshore-funded landowners against Bougainville Copper Limited, ordering indemnity costs in the company’s favor.

TMK Energy Limited has announced a significant security consolidation, merging every 55 existing securities into one, impacting shares, options, and performance rights with adjusted exercise prices.

Gold Road Resources has received Supreme Court approval for its Scheme, triggering a fully franked special dividend payable to shareholders in early October.

Elanor Investors Group has obtained a crucial ASX waiver allowing a longer timeframe to issue securities tied to its $125 million recapitalisation with Rockworth Investment. This move addresses regulatory delays and aims to stabilise Elanor's balance sheet and reduce gearing.

Super Retail Group Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 0.34 per share and a special dividend of AUD 0.30 per share, alongside an updated dividend reinvestment plan price of AUD 16.90.

Gold Road Resources’ acquisition by Gold Fields has been legally approved, triggering a special dividend and final scheme payments to shareholders. Trading of Gold Road shares will be suspended as the deal moves to completion.

Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.

Manuka Resources has gained approval for a secondary listing on the New Zealand Stock Exchange, enhancing trading access for local shareholders and supporting its strategic growth in critical and precious metals projects across New Zealand and Australia.

Future Metals NL has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but highlighting progress on appointing a new CEO.